A randomized phase II study of paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV non-squamous-non-small cell lung cancer: NVALT12
- Registry ID
- EUCTR2010-022104-50
- Source registry
- EUCTR
- Status
- Ongoing
- Phase
- PHASE2
- Sponsor
- Stichting NVALT Studies
- Start date
- 2010-08-19
- Last update
- 2026-08-16
Conditions
- metastatic non-squamous non-small-cell lung cancer
Summary
The addition of NTG patches to bevacizumab containing chemotherapy (experimental arm) improves PFS in patients with stage IV non-squamous NSCLC, compared to bevacizumab containing chemotherapy without NTG (control arm)
Locations
View on source registry